710 related articles for article (PubMed ID: 26346676)
1. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
Dobruch J; Daneshmand S; Fisch M; Lotan Y; Noon AP; Resnick MJ; Shariat SF; Zlotta AR; Boorjian SA
Eur Urol; 2016 Feb; 69(2):300-10. PubMed ID: 26346676
[TBL] [Abstract][Full Text] [Related]
2. Sex steroids and gender differences in nonmuscle invasive bladder cancer.
Lucca I; Fajkovic H; Klatte T
Curr Opin Urol; 2014 Sep; 24(5):500-5. PubMed ID: 24978392
[TBL] [Abstract][Full Text] [Related]
3. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
4. Gender discrepancies in bladder cancer: potential explanations.
Viswambaram P; Hayne D
Expert Rev Anticancer Ther; 2020 Oct; 20(10):841-849. PubMed ID: 32896196
[TBL] [Abstract][Full Text] [Related]
5. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
[TBL] [Abstract][Full Text] [Related]
6. Impact of gender on bladder cancer incidence, staging, and prognosis.
Fajkovic H; Halpern JA; Cha EK; Bahadori A; Chromecki TF; Karakiewicz PI; Breinl E; Merseburger AS; Shariat SF
World J Urol; 2011 Aug; 29(4):457-63. PubMed ID: 21656173
[TBL] [Abstract][Full Text] [Related]
7. Female bladder cancer: incidence, treatment, and outcome.
Scosyrev E; Trivedi D; Messing E
Curr Opin Urol; 2010 Sep; 20(5):404-8. PubMed ID: 20592613
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in incidence and outcomes of urothelial and kidney cancer.
Lucca I; Klatte T; Fajkovic H; de Martino M; Shariat SF
Nat Rev Urol; 2015 Oct; 12(10):585-92. PubMed ID: 26436686
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on gender-specific disparities in bladder cancer.
Mancini M; Righetto M; Baggio G
Urologia; 2020 Aug; 87(3):103-114. PubMed ID: 31868559
[TBL] [Abstract][Full Text] [Related]
10. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer survival: Women better off in the long run.
Andreassen BK; Grimsrud TK; Haug ES
Eur J Cancer; 2018 May; 95():52-58. PubMed ID: 29635144
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
13. Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?
Wolff I; Brookman-May S; May M
Curr Opin Urol; 2015 Sep; 25(5):418-26. PubMed ID: 26125505
[TBL] [Abstract][Full Text] [Related]
14. [Gender disparities in urologic cancers].
Lucca I; Valerio M; Jichlinski P; Cerantola Y
Rev Med Suisse; 2015 Dec; 11(497):2276-8, 2280. PubMed ID: 26785525
[TBL] [Abstract][Full Text] [Related]
15. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
16. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
[TBL] [Abstract][Full Text] [Related]
17. The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder.
Boorjian SA; Zhu F; Herr HW
BJU Int; 2010 Aug; 106(3):357-61. PubMed ID: 20002665
[TBL] [Abstract][Full Text] [Related]
18. The role of the androgen receptor in the development and progression of bladder cancer.
Li Y; Izumi K; Miyamoto H
Jpn J Clin Oncol; 2012 Jul; 42(7):569-77. PubMed ID: 22593639
[TBL] [Abstract][Full Text] [Related]
19. The impact of gender on oncologic outcomes of bladder cancer.
Mun DH; Kimura S; Shariat SF; Abufaraj M
Curr Opin Urol; 2019 May; 29(3):279-285. PubMed ID: 30855378
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences of ≥ pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients.
Waldhoer T; Berger I; Haidinger G; Zielonke N; Madersbacher S
Urol Int; 2015; 94(4):383-9. PubMed ID: 25833466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
